Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
Wuhan Union Hospital, Wuhan, Hubei, China
West China Hospital, Chengdu, Sichuan, China
Children's Hospital affiliated with Fudan University, Shanghai, China
Penn State Health Milton S Hershey Medical Center, Hershey, Pennsylvania, United States
Anesthesiology Department of Affiliated Eye and ENT Hospital, Fudan University, Shanghai, Shanghai, China
Fujian provincial hospital, Fuzhou, Fujian, China
Bekzat, Astana, Kazakhstan
Wunschbaby Institut Feichtinger, Vienna, Austria
Beijing Chaoyang Hospital, Capital Medical University, Beijing, Beijing, China
Southern Medical University Nanfang Hospital, Guangzhou, Guangdong, China
The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.